Assessment of ITGA2/B1 and ILK expression in a published Luminal breast cancer dataset was not consistent with the pro-aggressive implications of our association with EMT in the EDW-01 PDX, since ILK predicted improved regression-free survival post treatment. Here, ITGA2 is linked to breast carcinoma.